The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute
Global leader in generating knowledge to improve individual and population health through transformative learning, research, and dissemination about the effectiveness, safety, and value of medical products, services, and policies.
Learn More
Obstetric-fetal Pharmacology Research Unit (OPRU)
The University of Washington Obstetric-fetal Pharmacology Research Unit is dedicated to the optimization of medications during pregnancy and lactation. Our goal is to understand how the body handles and responds to drugs during pregnancy. Many medications commonly used during pregnancy and lactation are not well understood.
Learn More
Global Medicines Program
The Global Medicines Program improves the access, use, safety, quality, cost-effectiveness, and affordability of medicines in lower income countries by generating and disseminating new methods and knowledge on medicine safety and value, teaching and mentoring trainees, and strengthening pharmaceutical systems and services.
Learn More
Institute for Innovative Pharmacy Practice (I2P2)
I2P2 focuses on educating pharmacists who promote innovative and entrepreneurial solutions for better health — and better business. It also provides outreach and guidance to practicing pharmacists to help them better serve their patients in an ever-changing pharmacy landscape.
Learn More
Performance Based Risk Sharing Database
The Performance Based Risk Sharing (PBRS) web-enabled database is designed to be an up-to-date resource on performance-based risk sharing arrangements (also known as patient access schemes, market access agreements, and managed entry agreements, among others). The database was developed by the Pharmaceutical Outcomes Research & Policy Program at the University of Washington in collaboration with members of the School of Pharmacy’s corporate advisory board outcomes committee.
Learn More